- Home
- ANNX vs VMD Comparison
ANNX vs VMD Comparison
Compare ANNX & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- VMD
- Stock Information
- Founded
- ANNX 2011
- VMD 2006
- Country
- ANNX United States
- VMD United States
- Employees
- ANNX N/A
- VMD N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- VMD
- Sector
- ANNX Health Care
- VMD
- Exchange
- ANNX Nasdaq
- VMD Nasdaq
- Market Cap
- ANNX 334.1M
- VMD 280.4M
- IPO Year
- ANNX 2020
- VMD N/A
- Fundamental
- Price
- ANNX $2.92
- VMD $6.54
- Analyst Decision
- ANNX Strong Buy
- VMD
- Analyst Count
- ANNX 4
- VMD 0
- Target Price
- ANNX $13.00
- VMD N/A
- AVG Volume (30 Days)
- ANNX 1.9M
- VMD 145.3K
- Earning Date
- ANNX 11-10-2025
- VMD 11-05-2025
- Dividend Yield
- ANNX N/A
- VMD N/A
- EPS Growth
- ANNX N/A
- VMD 35.92
- EPS
- ANNX N/A
- VMD 0.34
- Revenue
- ANNX N/A
- VMD $254,794,000.00
- Revenue This Year
- ANNX N/A
- VMD $19.22
- Revenue Next Year
- ANNX N/A
- VMD $17.51
- P/E Ratio
- ANNX N/A
- VMD $19.20
- Revenue Growth
- ANNX N/A
- VMD 18.89
- 52 Week Low
- ANNX $1.29
- VMD $5.93
- 52 Week High
- ANNX $6.93
- VMD $9.68
- Technical
- Relative Strength Index (RSI)
- ANNX 45.55
- VMD 46.87
- Support Level
- ANNX $2.66
- VMD $6.05
- Resistance Level
- ANNX $3.03
- VMD $6.45
- Average True Range (ATR)
- ANNX 0.24
- VMD 0.21
- MACD
- ANNX -0.04
- VMD -0.02
- Stochastic Oscillator
- ANNX 26.98
- VMD 46.67
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.